Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5004)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 27, 2024 (publication date) through Jan 12, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Wong R, Yuan LY. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both. World J Hepatol 2024; 16(6): 871-877 [PMID: 38948439 DOI: 10.4254/wjh.v16.i6.871] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Wong R, Yuan LY. Sarcopenia and metabolic dysfunction associated steatotic liver disease: Time to address both. World J Hepatol 2024; 16(6): 871-877 [PMID: 38948439 DOI: 10.4254/wjh.v16.i6.871] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v16/i6/871.htm |
| Number | Citing Articles |
| 1 |
Sizhe Wan, Mingkai Li, Wanjun Li, Yuexiang Ren, Yuankai Wu, Qingtian Luo, Wei Gong. Development and validation of a multimodal model integrating gut microbiota and metabolite for identifying sarcopenia in patients with MASLD: a study from two centers in China. Nutrition Journal 2025; 24(1) doi: 10.1186/s12937-025-01198-2
|
| 2 |
Yanyan Xuan, Fangfang He, Qing Liu, Dandan Dai, Dingting Wu, Yanmei Shi, Qi Yao. Elevated GGT to HDL ratio as a marker for the risk of NAFLD and liver fibrosis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-024-84649-w
|
| 3 |
Jiawen Dong, Kaitlyn M J H Dennis, Radha Venkatakrishnan, Leanne Hodson, Jeremy W Tomlinson. The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy. Endocrine Reviews 2025; 46(6): 790 doi: 10.1210/endrev/bnaf018
|
| 4 |
Carlos Jiménez-Cortegana, Soledad López-Enríquez, Gonzalo Alba, Consuelo Santa-María, Gracia M. Martín-Núñez, Francisco J. Moreno-Ruiz, Sergio Valdés, Sara García-Serrano, Cristina Rodríguez-Díaz, Ailec Ho-Plágaro, María I. Fontalba-Romero, Eduardo García-Fuentes, Lourdes Garrido-Sánchez, Víctor Sánchez-Margalet. The Expression of Genes Related to Reverse Cholesterol Transport and Leptin Receptor Pathways in Peripheral Blood Mononuclear Cells Are Decreased in Morbid Obesity and Related to Liver Function. International Journal of Molecular Sciences 2024; 25(14): 7549 doi: 10.3390/ijms25147549
|
| 5 |
Fan Zhang, Wenjian Li. Correlation Between Metabolic Dysfunction-Associated Steatotic Liver Disease and the Risk of Urinary Incontinence in Adult Women. International Journal of Women's Health 2024; : 1607 doi: 10.2147/IJWH.S489959
|
| 6 |
Yan Li, Wei Feng, Xiaojie Sun, Yujie Dong. Causal and mediating link between sarcopenia and nonalcoholic fatty liver disease: A bidirectional two-sample, two-step Mendelian randomization study. Nutrition, Metabolism and Cardiovascular Diseases 2025; 35(12): 104207 doi: 10.1016/j.numecd.2025.104207
|
| 7 |
Yea-Chan Lee, Hye Sun Lee, Soyoung Jeon, Yae-Ji Lee, Yu-Jin Kwon, Ji-Won Lee. Assessing Nutritional Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease via Diverse Statistical Tools. Diabetes & Metabolism Journal 2026; 50(1): 178 doi: 10.4093/dmj.2025.0026
|
| 8 |
Shinya Sato, Hiroaki Takaya, Tadashi Namisaki, Tatsuya Nakatani, Jun-ichi Hanatani, Yuki Tsuji, Koh Kitagawa, Norihisa Nishimura, Kosuke Kaji, Hitoshi Yoshiji. Diabetes as a Risk Factor for Sarcopenia in Patients with MASH-Related Cirrhosis. Journal of Clinical Medicine 2025; 14(24): 8691 doi: 10.3390/jcm14248691
|
| 9 |
Sampada, Mohammad Naseem, Mehul Solanki, Ragini Sharma, Carol Singh, Aalam Sohal. Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease. World Journal of Gastrointestinal Pathophysiology 2025; 16(4): 111029 doi: 10.4291/wjgp.v16.i4.111029
|
| 10 |
Fan Zhang, Longgen Liu, Wenjian Li. Correlation of sarcopenia with progression of liver fibrosis in patients with metabolic dysfunction-associated steatotic liver disease: a study from two cohorts in China and the United States. Nutrition Journal 2025; 24(1) doi: 10.1186/s12937-025-01081-0
|
| 11 |
Consensus guidelines for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease in adult Asian Indians with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2025; 19(3): 103209 doi: 10.1016/j.dsx.2025.103209
|
| 12 |
Shuangshuang Hou, Yang Yu, Nanbo Li, Wenjing Yu, Zhiyuan Dai, He Li, Lianyi Guo, Jiajun Yin, Ju Wu. Preoperative albumin-bilirubin grade combined with sarcopenia predicts long-term outcomes after laparoscopic gastrectomy for advanced gastric cancer. BMC Gastroenterology 2025; 25(1) doi: 10.1186/s12876-025-04173-7
|
| 13 |
Marwan S Al-Nimer. Sarcopenia and metabolic dysfunction-associated steatotic liver disease: The role of exercise-related biomarkers. World Journal of Hepatology 2025; 17(2): 101165 doi: 10.4254/wjh.v17.i2.101165
|
| 14 |
Anoushka Shenoy, Aijaz Ahmed, Donghee Kim. Extrahepatic manifestation of metabolic dysfunction-associated steatotic liver disease. Metabolism and Target Organ Damage 2025; 5(3) doi: 10.20517/mtod.2025.73
|